Rocket Lab reports Q3 earnings tonight, and investors will be watching Neutron above all else.
The company’s Q4 2026 launch pad delivery target is approaching fast, which makes any update on Neutron’s development schedule a potential stock-moving catalyst.
Wall Street expects $257.18 million in revenue, compared with management’s guidance of $250 million to $265 million. However, GAAP gross margins are expected to fall to 29%–31%, down from 36.1% last quarter.
The big question tonight: Can management reassure investors that Neutron remains on schedule, or will another potential delay raise concerns about cash burn and future dilution?
Neutron has come up on every call for the past year, and with first launch now pushed to no earlier than 2027, the 5pm ET call is where analysts will press for a credible date. The margin thread matters just as much after non-GAAP gross margin slipped to 38.4% from 41.9% a year ago, which tests the bull case we laid out at 4:10pm that cadence closes the loss gap before Neutron flies.
Backlog jumped 52% in a single quarter to a record $3.57 billion, built on roughly $1 billion of new launch contracts signed in Q3. Revenue beat expectations while the GAAP loss missed expectations on debt extinguishment and Iridium deal costs. Q4 revenue guidance of $270 million to $290 million keeps the growth curve intact.
“Rocket Lab's launch cadence scales revenue fast enough to close the loss gap before Neutron flies”
Bull case
Q3 revenue of $267.83 million beat the $257.18 million consensus, up 73% year over year and 14% from Q2
revenue landed above the top of management's $250 million to $265 million guidance range
operating margin had already narrowed to -24.6% in Q2 2026 from -49.5% two years earlier
shares up double digits on the report despite prediction markets pricing only a 37% chance of a beat
Bear case
EPS of -$0.12 missed the -$0.07 estimate, with losses widening as revenue climbs
Q2 2026 gross margin slipped to 36.1% from 38.2% in Q1, the first step back in two years
Neutron pad delivery target sits in Q4 2026 with no revenue from the larger vehicle yet
stock still 25% below its 200-day average going into the report
The 73% revenue jump tips it: cadence is scaling faster than Wall Street modeled, and investors appear willing to fund the losses while that holds. The wider EPS miss is the crack to watch. A second straight quarter of falling gross margin, or any slip in the Q4 Neutron pad timeline, would turn this to weakening.
Rocket Lab just reported Q3 2026 earnings, with shares initially up 1% following the report. Revenue topped expectations, although losses were significantly wider than Wall Street anticipated.
Revenue: $267.83 million vs. $257.18 million expected 🟢
EPS: -$0.12 vs. -$0.07 expected 🔴
Quick Read:
Revenue beat expectations by 4%, climbing 73% year over year and 14% quarter over quarter.
Losses widened significantly, with EPS missing estimates by roughly 71%, raising questions about profitability as Rocket Lab continues investing in its expansion.
Investors will now be watching for management’s latest updates on the Neutron rocket program and its development timeline.
Rocket Lab's gross margin has climbed from 26.7% in Q3 2024 to the mid-30s, but it slipped to 36.1% in Q2 2026 from 38.2% in Q1, the first step back in two years. Operating margin keeps narrowing (-24.6% in Q2 2026 versus -49.5% two years ago), so tonight's question is whether Neutron spending stalls that progress or the launch mix pushes gross margin back above 38%.
Rocket Lab goes into tonight's report at $59.05, pinned below both its 50-day average of $62.45 and the $61.13 resistance shelf, with the 200-day way up at $78.72. Resistance at $61.13 is the level that matters: reclaiming it is the first step toward repairing a chart that sits less than half of the $151 52-week high. Missing expectations puts $49.25 support back in play.
Market participants are leaning against an earnings beat tonight, assigning well under a 50% probability that Rocket Lab clears the GAAP EPS line. That skepticism sits awkwardly next to a $35.2 billion market cap and the Neutron pad timeline investors flagged this morning, so any surprise on the bottom line cuts against where the crowd is positioned.
A 0.45 put/call ratio into tonight's report means calls outnumber puts better than two to one, with the heaviest open interest stacked at the $55 strike just above the $54 at-the-money line. That positioning shows traders leaning hard toward an upside Neutron update, and the one-sided call crowding leaves little cushion if the news disappoints. At-the-money implied volatility of 132.2% on the Nov. 13 expiration shows how violent the reaction is expected to be either way.
Q2 showed Rocket Lab can keep revenue climbing on launch cadence while the bottom line stays in the red, and tonight's numbers land with expectations already reset since that August report. With the Neutron pad delivery target we flagged this afternoon now inside the next quarter, the Q3 update matters more for the schedule than for the revenue line.
As of Jun 30, 2026 quarter end · 13F disclosures lag ~45 days — long positions only, tracked filers only.
Among the eight filers disclosing positions, the two biggest holders of Rocket Lab were both trimming as of June 30, with ARK still sitting on roughly $166 million of the stock after cutting its share count. Renaissance Technologies and Point72 opened new positions in the same quarter, so these filers went into tonight's report split four buyers to three trimmers. Note these disclosures are about 45 days stale and predate the Q3 setup entirely.
Rocket Lab reports Q2 earnings tonight carrying a $2.2 billion backlog, two massive defense wins, and shares up 15% in a week, but prediction markets put 93.5% odds on the stock closing red today.…
Investors are watching Rocket Lab (NASDAQ: RKLB | RKLB Price Prediction) ahead of first-quarter 2026 results due May 7. After a record fourth quarter and a stumble by Neutron, this earnings report will test…
Rocket Lab USA (NASDAQ: RKLB | RKLB Price Prediction) reports Q4 FY2025 earnings today, and the stakes are high. With shares up 230% over the past year but down nearly 12% over the past…
Rocket Lab just pushed its biggest growth engine into 2027 while posting record revenue, leaving investors to decide whether the selloff is a buying opportunity or a warning sign they cannot afford to ignore.
Rocket Lab enters 2026 with a record backlog, a transformative acquisition pending, and a brand-new rocket on the launchpad, but whether those pieces come together determines if the stock doubles or stalls out entirely.
Rocket Lab (Nasdaq: RKLB | RKLB Price Prediction) will report Q2 2025 results after the close today. The space launch and satellite components provider enters this print with strong revenue momentum, yet profitability remains…
Rocket Lab (NASDAQ: RKLB | RKLB Price Prediction) and AST SpaceMobile (NASDAQ: ASTS) both shed between 26 and 27% over the past month, but the reasons behind each selloff tell very different stories about…
A carbon-composite dome no bigger than the top of a propellant tank just shook billions in market value and pushed Rocket Lab's most important bet to a launch date the company has not yet…
Rocket Lab (NASDAQ: RKLB | RKLB Price Prediction) beat on both revenue and earnings in Q3 while posting record gross margins, sending the stock surging 8.3% in after-hours trading. The space launch company reported…
